Susquehanna Fundamental Investments’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-11,167
| Closed | -$1.17M | – | 884 |
|
|
2025
Q1 | $1.17M | Buy |
+11,167
| New | +$1.17M | 0.02% | 654 |
|
|
2023
Q2 | – | Sell |
-9,470
| Closed | -$697K | – | 779 |
|
|
2023
Q1 | $697K | Hold |
9,470
| – | – | 0.02% | 606 |
|
|
2022
Q4 | $633K | Sell |
9,470
-13,405
| -59% | -$895K | 0.01% | 791 |
|
|
2022
Q3 | $1.23M | Buy |
+22,875
| New | +$1.23M | 0.02% | 736 |
|
|
2022
Q1 | $540K | Buy |
+7,694
| New | +$540K | 0.01% | 1045 |
|